-+ 0.00%
-+ 0.00%
-+ 0.00%

Royalty Pharma EVP, Research & Investments Marshall Urist Reports Sale of $1.74 Million in Common Shares

PUBT·11/18/2026 21:14:36
Listen to the news
Royalty Pharma EVP, Research & Investments Marshall Urist Reports Sale of $1.74 Million in Common Shares
  • Royalty Pharma EVP, Research & Investments Marshall Urist sold 25,000 Class A Ordinary Shares on November 16, 2026.
  • Sales comprised 23,592 shares at $69.4701 and 1,408 shares at $69.9941.
  • Remaining Class A Ordinary Shares totaled 125,000 through Sandy Lamm LLC, 19,020 through an IRA and 5,341 directly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001838139-26-000033), on November 18, 2026, and is solely responsible for the information contained therein.